Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis.
Leypoldt
F
F
Eichhorn
P
P
Saager
C
C
Münchau
A
A
Lewerenz
J
J
D000368:Aged; D000951:Antigens, Neoplasm / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009188:Myelitis, Transverse / Q000188:drug therapy* / Q000276:immunology*; D009419:Nerve Tissue Proteins / Q000276:immunology; D000090682:Neuro-Oncological Ventral Antigen; D016601:RNA-Binding Proteins / Q000276:immunology; D013256:Steroids / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D007166:Immunosuppressive Agents; D009419:Nerve Tissue Proteins; D000090682:Neuro-Oncological Ventral Antigen; D016601:RNA-Binding Proteins; D013256:Steroids; D003520:Cyclophosphamide